Abstract
Intravenous iron therapy for patients with heart failure: expanding body of evidence.
Highlights
Anaemia represents a common co-morbidity in patients with heart failure (HF)
As ferritin represents an acute phase mediator, these cut-off levels cannot be used in HF, a disease marked by chronic inflammation
In their post hoc analysis of FAIR-HF, Onoko et al confirmed that calculated plasma volume status predicts death and hospitalizations in a chronic HF cohort
Summary
Anaemia (haemoglobin
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
